Monica Parker

, MD

Associate Professor of Medicine, Department of Neurology; Director, Outreach Recruitment and Education Core; Director, Minority Engagement Core, Goizueta Alzheimer's Disease Research Center, Emory University

Monica Willis Parker, MD, is a graduate of Fisk University and the University of Nebraska Medical Center. She joined the Emory School of Medicine faculty in 1995. She has transitioned roles as a geriatric primary care provider to that of clinical research investigator. She now leads the Minority Engagement Core (MEC), one of six cores of the Emory Goizueta Alzheimer’s Disease Research Center. Dr. Parker serves as Co-investigator on several NIH-funded projects. She advocates and educates about the importance of research participation for the elimination of health disparities in persons of color. She has co-authored several peer reviewed articles on the differences in neurocognitive disorders between African and European Americans, African American caregiving needs, and research participation for African Americans with colleagues at Emory, the Mayo Clinic, and Ohio State University.

Active in many civic and social organizations, most notably, she was appointed the inaugural Health and Human Services Facet Director of The Links Incorporated (2010-2014). She serves on several boards, which include AGRHODES Nursing and Rehab centers, Georgia Alzheimer’s Association Board of Governors, the Health Outcomes Task force for the National Alzheimer’s Association, Georgia Museum of Art (GMOA), and the Chief Justice’s Commission on Professionalism for the State Bar of Georgia.

A recipient of several honors, she was named Atlanta Magazine’s “Groundbreaker of the Year”; “A Key to A Cure” Award recipient of the Wesley Woods Foundation; and one of Atlanta’s Top Doctors, in Family/Geriatric Medicine 2009-2013, by Castle-Connolly Associates.

Read more

This Speaker's Sessions

PANEL
Wednesday Oct. 16
-
1:30–2:20 PM ET
Watch Replay
Now Live!

The Patient Pathway: Beginning the Journey with Cognitive Impairment

For many diseases, well-defined diagnostic and care pathways guide patients, doctors, and caregivers through the patient journey. That is not the case for Alzheimer’s. This panel will discuss what that pathway should look like, starting from the moment a patient prepares to discuss their brain health with their doctor, through subsequent referrals to specialists and treatment options, to exploring potential involvement in clinical trials. Key Question: What needs to happen so that people with cognitive impairment have a smooth path to a reliable diagnosis, appropriate treatment, and access to clinical trials?

View SessionWatch Replay